Skip to main content
Navneet Majhail, MD, Hematology, Nashville, TN, TriStar Centennial Medical Center

NavneetSinghMajhailMD, MS, FASTCT

Hematology Nashville, TN

Hematologic Oncology

Physician-in-Chief of Blood Cancers, Sarah Cannon; Director, Sarah Cannon Transplant & Cellular Therapy Program at TriStar Centennial; President (2019), American Society for Transplantation and Cellular Therapy

Dr. Majhail is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Majhail's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
  • Government Medical College Chandigrah
    Government Medical College ChandigrahClass of 1997

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2021 - 2026
  • NV State Medical License
    NV State Medical License 2023 - 2025
  • OH State Medical License
    OH State Medical License 2000 - 2022
  • FL State Medical License
    FL State Medical License 2016 - 2020
  • MN State Medical License
    MN State Medical License 2006 - 2014
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
    Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature

Abstracts/Posters

  • Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
    Navneet S. Majhail, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • How to Set up a Health Services and Outcomes Research Program 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Navneet Majhail Named Deputy Physician-in-Chief of Blood Cancers at Sarah Cannon
    Navneet Majhail Named Deputy Physician-in-Chief of Blood Cancers at Sarah CannonJune 25th, 2021
  • A Deep Dive into HLA Typing for Unrelated Donor Hematopoietic Cell Transplantation
    A Deep Dive into HLA Typing for Unrelated Donor Hematopoietic Cell TransplantationMay 20th, 2021
  • Piner Man Is Cleveland Clinic's First MS Patient for Special Treatment
    Piner Man Is Cleveland Clinic's First MS Patient for Special TreatmentFebruary 28th, 2021

Professional Memberships

Hospital Affiliations